In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss
K., AlSayed, M., Mehta, V., Chopra, R., & Mantri, N
287 , E199E206 (2004)
Needle-free jet injectors like the Comfort-in are now available to make injecting for children (including self-administered injections) a simple, safe and stress-free process